Ad is loading...
PRFDX
Price
$38.71
Change
+$0.01 (+0.03%)
Updated
Nov 15 closing price
RMFCX
Price
$58.23
Change
-$0.50 (-0.85%)
Updated
Nov 15 closing price
Ad is loading...

PRFDX vs RMFCX

Header iconPRFDX vs RMFCX Comparison
Open Charts PRFDX vs RMFCXBanner chart's image
T. Rowe Price Equity Income
Price$38.71
Change+$0.01 (+0.03%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$58.23
Change-$0.50 (-0.85%)
VolumeN/A
CapitalizationN/A
PRFDX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRFDX vs. RMFCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRFDX is a Buy and RMFCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. PRFDX (17.9B). PRFDX pays higher dividends than RMFCX: PRFDX (1.84) vs RMFCX (1.69). PRFDX was incepted earlier than RMFCX: PRFDX (39 years) vs RMFCX (22 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. PRFDX (16.70). RMFCX has a lower initial minimum investment than PRFDX: RMFCX (250) vs PRFDX (2500). RMFCX (21.31) and PRFDX (20.70) have marching annual gain over last year. RMFCX return over 5 years is better than : 44.92 vs. PRFDX (26.80).
PRFDXRMFCXPRFDX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence39 years22 years-
Gain YTD16.63116.440101%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17.9B104B17%
Annual Yield % from dividends1.841.69109%
Returns for 1 year20.7021.3197%
Returns for 3 years6.8715.4644%
Returns for 5 years26.8044.9260%
Returns for 10 years29.8465.0146%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS0.630.01
+1.10%
Momentus
WWW21.79-0.24
-1.09%
Wolverine World Wide
SNAP10.60-0.16
-1.49%
Snap
SHC14.31-0.68
-4.54%
Sotera Health Company
ENTA9.53-0.60
-5.92%
Enanta Pharmaceuticals